GlassScriptPhysician profile
Vuthik Chhay
NPI 1558484196
$5,022.49
in general payments reported to CMS, 2019-2025
34 companies · $725 in 2025
The $725 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,348 · 2022: $1,093 · 2023: $664 · 2024: $1,193 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,581.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,276.77 | 2021-2024 | Erleada, Akeega |
| Astellas Pharma US INC | $782.84 | 2021-2025 | Xtandi |
| Abbvie INC. | $528.14 | 2021-2024 | |
| Pfizer INC. | $457.65 | 2021-2025 | |
| Blue Earth Diagnostics | $276.11 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $258.37 | 2023-2025 | Gemtesa |
| Axonics, INC. | $164.27 | 2021-2024 | Axonics, Bulkamid |
| Teleflex LLC | $156.57 | 2021-2024 | Urolift |
| Procept Biorobotics Corporation | $148.23 | 2022-2025 | Aquabeam System |
| Travere Therapeutics, INC. | $136.76 | 2021-2022 | |
| Urogen Pharma, INC. | $98.67 | 2025 | |
| Tolmar, INC. | $63.48 | 2025 | Eligard, Jatenzo |
| Astrazeneca Pharmaceuticals LP | $56.58 | 2021 | |
| Boston Scientific Corporation | $53.18 | 2022-2025 | Axonics |
| Antares Pharma, INC. | $51.43 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $45.36 | 2022-2023 | Xgeva |
| Myriad Genetic Laboratories, INC. | $44.03 | 2022-2024 | Prolaris |
| Medtronic, INC. | $41.61 | 2022 | |
| 180 Medical, INC. | $38.80 | 2023-2024 | Gentlecath, Gentlecath Glide |
| Clarus Therapeutics INC. | $38.57 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $36.37 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $34.98 | 2024 | Exparel |
| Novartis Pharmaceuticals Corporation | $29.40 | 2025 | |
| Ferring Pharmaceuticals INC. | $24.87 | 2025 | Adstiladrin |
| Olympus America INC. | $24.10 | 2022 | |
| Laborie Medical Technologies Corp. | $22.68 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Dentsply Ih Ab | $20.76 | 2024 | Lofric |
| Myovant Sciences INC. | $20.38 | 2021 | |
| Verity Pharmaceuticals INC. | $18.69 | 2023 | Trelstar |
| Bayer Healthcare Pharmaceuticals INC. | $17.59 | 2021 | |
| Mission Pharmacal Company | $15.42 | 2021 | |
| Hollister Incorporated | $13.72 | 2021 | |
| Merck Sharp & Dohme LLC | $13.50 | 2021 | |
| Urovant Sciences INC | $12.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vuthik Chhay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.